Telomerase inhibition, telomerase shortening, and senescence of cancer cells by tea catechins

被引:203
|
作者
Naasani, I
Seimiya, H
Tsuruo, T
机构
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1708455, Japan
[2] Univ Tokyo, Inst mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
基金
日本科学技术振兴机构;
关键词
D O I
10.1006/bbrc.1998.9075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Animal in vivo studies and human epidemiological observations indicated potent anticancer effects for tea. Here we demonstrate that epigallocatechin gallate (EGCG), a major tea catechin, strongly and directly inhibits telomerase, an enzyme essential for unlocking the proliferative capacity of cancer cells by maintaining the tips of their chromosomes. Telomerase inhibition was elaborated in a cell-free system (cell extract) as well as in living cells. In addition, the continued growth of two representative human cancer cell lines, U937 monoblastoid leukemia cells and HT29 colon adenocarcinoma cells, in the presence of nontoxic concentrations of EGCG showed life span limitations accompanied with telomere shortening, chromosomal abnormalities, and expression of the senescence-associated beta-galactosidase. It is suggested that telomerase inhibition could be one of the major mechanisms underlying the anticancer effects of tea. (C) 1998 Academic Press.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [21] TELOMERES, TELOMERASE AND SENESCENCE
    GREIDER, CW
    BIOESSAYS, 1990, 12 (08) : 363 - 369
  • [22] Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
    Saretzki, G
    Ludwig, A
    von Zglinicki, T
    Runnebaum, IB
    CANCER GENE THERAPY, 2001, 8 (10) : 827 - 834
  • [23] Telomerase, senescence and ageing
    Shawi, May
    Autexier, Chantal
    MECHANISMS OF AGEING AND DEVELOPMENT, 2008, 129 (1-2) : 3 - 10
  • [24] Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
    Gabriele Saretzki
    Antje Ludwig
    Thomas von Zglinicki
    Ingo B Runnebaum
    Cancer Gene Therapy, 2001, 8 : 827 - 834
  • [25] Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
    Runnebaum, IB
    Saretzki, G
    Ludwig, A
    von Zglinicki, T
    CANCER GENE THERAPY, 2001, 8 : S2 - S2
  • [26] Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component
    Liu, BL
    Qu, Y
    Liu, SQ
    Ouyang, XS
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2002, 45 (01): : 87 - 95
  • [27] Mechanism of acridine-based telomerase inhibition and telomere shortening
    Gunaratnam, Mekala
    Greciano, Olga
    Martins, Cristina
    Reszka, Anthony P.
    Schultes, Christoph M.
    Morjani, Hamid
    Riou, Jean-Francois
    Neidle, Stephen
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (05) : 679 - 689
  • [28] Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component
    刘柏林
    屈艺
    欧阳雪松
    刘菽秋
    Science in China(Series C:Life Sciences) , 2002, (01) : 87 - 95
  • [29] Inhibition of telomerase in tumor cells by ribozyme targeting telomerase RNA component
    Bailin Liu
    Yi Qu
    Shuqiu Liu
    Xuesong Ouyang
    Science in China Series C: Life Sciences, 2002, 45 : 87 - 95
  • [30] Inhibition of telomerase activity by cisplatin in human testicular cancer cells
    Burger, AM
    Double, JA
    Newell, DR
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) : 638 - 644